RNA-based analysis of BRCA1 and BRCA2 gene alterations.

Alterations in BRCA1 and BRCA2 genes account for a large proportion of hereditary breast and ovarian cancers. Mutations and variants of unknown pathological significance have been identified in both genes; however, most of them have been studied only at the genomic level, and their effect on mRNA expression remains unknown. We identified two BRCA1 and six BRCA2 splice site variants, and one BRCA2 alteration at exon 14. Our aim was to ascertain the effect on RNA processing of the variants still unclassified. We found that BRCA1 c.IVS11 + 1G>A, BRCA2 c.7252_7272delinsTG, BRCA2 c.IVS2 + 1G>A, BRCA2 c.IVS13-2A>G, BRCA2 c.IVS21 + 4A>G, and BRCA2 c.9345G>A lead to aberrant transcripts in lymphocytes. Five of these six splice site variants caused a complete inactivation of the mutant allele because they produced frameshift similar to previously described deleterious exonic variants. Therefore, we consider them to be true deleterious mutations, possibly associated with an increased lifetime risk of breast or ovarian cancer. BRCA1 c.IVS17 + 6C>G, BRCA2 c.IVS12-9del4, and BRCA2 IVS1-9del3 represent rare variants, not disrupting normal mRNA processing. The last two BRCA2 genetic variants had not been reported in the Breast Cancer Information Core BIC database.

[1]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[2]  H. Feilotter,et al.  Alternatively spliced, truncated human BRCA2 isoforms contain a novel coding exon , 2003, European Journal of Human Genetics.

[3]  G. Parmigiani,et al.  Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations , 2004, European Journal of Human Genetics.

[4]  Olufunmilayo I Olopade,et al.  BRCA2 T2722R is a deleterious allele that causes exon skipping. , 2002, American journal of human genetics.

[5]  Gil Ast,et al.  How did alternative splicing evolve? , 2004, Nature Reviews Genetics.

[6]  B. Ward,et al.  A Biochemical analysis demonstrates that the BRCA1 intronic variant IVS10-2A→C is a mutation , 2003, Journal of Human Genetics.

[7]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[8]  M. Dumont,et al.  A new alternative splice variant of BRCA1 containing an additional in-frame exon. , 2005, Biochimica et biophysica acta.

[9]  L. V. van't Veer,et al.  Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. , 2003, Cancer research.

[10]  W. Henn,et al.  Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants , 2006, Human Genetics.

[11]  C. Cole,et al.  Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. , 1996, Cancer research.

[12]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[13]  C. Alonso,et al.  RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain , 2003, Human mutation.

[14]  P. Chappuis,et al.  Significant Contribution of Germline BRCA2 Rearrangements in Male Breast Cancer Families , 2004, Cancer Research.

[15]  E. Oláh,et al.  Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines. , 2001, Biochemical and biophysical research communications.

[16]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[17]  Ludwine Messiaen,et al.  Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2 , 2003, Genes, chromosomes & cancer.

[18]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[19]  E. Oláh,et al.  Emerging roles of BRCA1 alternative splicing , 2003, Molecular pathology : MP.

[20]  S. Antonarakis,et al.  Nomenclature for the description of human sequence variations , 2001, Human Genetics.

[21]  D. Horn,et al.  The BRCA2 variant 8204G>A is a splicing mutation and results in an in frame deletion of the gene , 2003, Journal of medical genetics.

[22]  D. Berry,et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.